Compare · BTI vs CGC
BTI vs CGC
Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Canopy Growth Corporation (CGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTI and CGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- BTI is the larger of the two at $122.79B, about 668.4x CGC ($183.7M).
- BTI has been more active in the news (9 items in the past 4 weeks vs 3 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 17 for BTI).
- Company
- British American Tobacco Industries p.l.c.
- Canopy Growth Corporation
- Price
- -
- -
- Market cap
- $122.79B
- $183.7M
- 1M return
- -
- -35.03%
- 1Y return
- -
- -62.27%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- News (4w)
- 9
- 3
- Recent ratings
- 17
- 19
British American Tobacco Industries p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest BTI
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Analyst resumed coverage on British American Tobacco
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Organigram to Acquire Aurora and Establish a Global Cannabis Leader
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- British American Tobacco upgraded by Goldman
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
Latest CGC
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
- SEC Form 10-Q filed by Canopy Growth Corporation
- Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
- SEC Form DEFA14A filed by Canopy Growth Corporation